re: fda approval Thats right, it opens up all sorts of questions. Remember that coramsine did show partial responses and a long term remission out of the 6 only patients that completed the full treatment . These were late stage refractory patients for whome there was no other treatment. Depends on interpretation I guess.
One of the responses was NSCLC, the biggest killer cancer in the USA
- Forums
- ASX - By Stock
- SBP
- re: fda approval
SBP
solbec pharmaceuticals limited
re: fda approval, page-2
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online